Bargou RC - Search Results

1

Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma.

Knop S, Langer C, Engelhardt M, Mügge LO, Reichle A, Rösler W, Bassermann F, Hertenstein B, Kunitz A, Röllig C, Ostermann H, Schäfer-Eckart K, Ringhoffer M, Günther A, Junghanss C, Biersack H, Schreder M, Liebert A, Held S, Einsele H, Bargou RC. Knop S, et al. Among authors: bargou rc. Leukemia. 2017 Aug;31(8):1816-1819. doi: 10.1038/leu.2017.124. Epub 2017 Apr 25. Leukemia. 2017. PMID: 28439106 Clinical Trial. No abstract available.

2

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.

Knop S, Engelhardt M, Liebisch P, Meisner C, Holler E, Metzner B, Peest D, Kaufmann M, Bunjes D, Straka C, Fischer T, Sezer O, Hentrich M, Ostermann H, Bassermann F, Hess G, Hertenstein B, Freund M, Kropff M, Schmidt CA, Wolf HH, Jung W, Frickhofen N, Mielke S, Bargou RC, Maschmeyer G, Svaldi M, Langer CH, Gramatzki M, Hebart H, Kanz L, Einsele H; Deutsche Studiengruppe Multiples Myelom. Knop S, et al. Among authors: bargou rc. Leukemia. 2019 Nov;33(11):2710-2719. doi: 10.1038/s41375-019-0537-2. Epub 2019 Aug 28. Leukemia. 2019. PMID: 31462732 Clinical Trial.

3

Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma.

Stühmer T, Zöllinger A, Siegmund D, Chatterjee M, Grella E, Knop S, Kortüm M, Unzicker C, Jensen MR, Quadt C, Chène P, Schoepfer J, García-Echeverría C, Einsele H, Wajant H, Bargou RC. Stühmer T, et al. Among authors: bargou rc. Leukemia. 2008 Aug;22(8):1604-12. doi: 10.1038/leu.2008.111. Epub 2008 May 15. Leukemia. 2008. PMID: 18480838

4

Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS.

Müller E, Bauer S, Stühmer T, Mottok A, Scholz CJ, Steinbrunn T, Brünnert D, Brandl A, Schraud H, Kreßmann S, Beilhack A, Rosenwald A, Bargou RC, Chatterjee M. Müller E, et al. Among authors: bargou rc. Leukemia. 2017 Apr;31(4):922-933. doi: 10.1038/leu.2016.264. Epub 2016 Sep 30. Leukemia. 2017. PMID: 27686868

5

Detecting the JAK2 V617F mutation in fresh and 'historic' blood and bone marrow.

Gattenlohner S, Peter C, Bonengel M, Einsele H, Bargou R, Müller-Hermelink HK, Marx A. Gattenlohner S, et al. Leukemia. 2007 Jul;21(7):1599-602. doi: 10.1038/sj.leu.2404701. Epub 2007 Apr 26. Leukemia. 2007. PMID: 17460708 No abstract available.

6

A novel recombinant bispecific single-chain antibody, bscWue-1 x CD3, induces T-cell-mediated cytotoxicity towards human multiple myeloma cells.

Hönemann D, Kufer P, Rimpler MM, Chatterjee M, Friedl S, Riecher F, Bommert K, Dörken B, Bargou RC. Hönemann D, et al. Among authors: bargou rc. Leukemia. 2004 Mar;18(3):636-44. doi: 10.1038/sj.leu.2403264. Leukemia. 2004. PMID: 14737072

7

Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia.

Topp MS, Stelljes M, Zugmaier G, Barnette P, Heffner LT Jr, Trippett T, Duell J, Bargou RC, Holland C, Benjamin JE, Klinger M, Litzow MR. Topp MS, et al. Among authors: bargou rc. Leukemia. 2018 Feb;32(2):562-565. doi: 10.1038/leu.2017.306. Epub 2017 Oct 9. Leukemia. 2018. PMID: 28990581 Free PMC article. No abstract available.

8

PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells.

Lentzsch S, Chatterjee M, Gries M, Bommert K, Gollasch H, Dörken B, Bargou RC. Lentzsch S, et al. Among authors: bargou rc. Leukemia. 2004 Nov;18(11):1883-90. doi: 10.1038/sj.leu.2403486. Leukemia. 2004. PMID: 15356648

9

Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors.

Aldoss I, Bargou RC, Nagorsen D, Friberg GR, Baeuerle PA, Forman SJ. Aldoss I, et al. Among authors: bargou rc. Leukemia. 2017 Apr;31(4):777-787. doi: 10.1038/leu.2016.391. Epub 2016 Dec 28. Leukemia. 2017. PMID: 28028314 Review.

10

Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells.

Janz M, Stühmer T, Vassilev LT, Bargou RC. Janz M, et al. Among authors: bargou rc. Leukemia. 2007 Apr;21(4):772-9. doi: 10.1038/sj.leu.2404565. Epub 2007 Feb 1. Leukemia. 2007. PMID: 17268519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters